Literature DB >> 8990478

[C-type hepatitis in spontaneous intracerebral hemorrhage].

T Aiba1, T Watanabe, T Koike, Y Arakawa.   

Abstract

The prevalence of hepatitis C virus (HCV) in 139 cases of spontaneous intracerebral hemorrhage (ICH) was investigated with regard to a diagnosis of hypertension. Patients under 30 and over 79 years of age were omitted from this study, and those with complicating malignancies and undergoing anti-coagulation or antiplatelet therapy were also excluded. The prevalence of HCV was significantly higher among the ICH group as a whole (19 out of 139 cases, p < 0.05) especially in the non-hypertensive group (7 out of 29 cases, p < 0.01), compared to the control group (7 out of 140 cases without ICH). The non-hypertensive HCV-positive group (7 cases) had significantly higher GOT and GPT levels, prolonged PT and a-PTT values, and lower platelet counts, compared to the hypertensive HCV-negative group (74 cases). The HCV antibody titers did not differ among the HCV-positive groups. The results suggest that chronic hepatitis due to HCV infection is a major risk factor for spontaneous intracerebral hemorrhage, especially in non-hypertensive patients.

Entities:  

Mesh:

Year:  1996        PMID: 8990478

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  3 in total

1.  Resolution of neurological deficits secondary to spontaneous intracranial haemorrhage and posterior reversible encephalopathy syndrome (PRES) in a patient with hepatitis C-associated cryoglobulinaemia: a role for plasmapheresis.

Authors:  Delshad Ahmad; Haseeb Ilias Basha; Basim Towfiq; Ghassan Bachuwa
Journal:  BMJ Case Rep       Date:  2014-01-20

Review 2.  Neurological complications of hepatitis C infection.

Authors:  Micheline McCarthy; Melissa R Ortega
Journal:  Curr Neurol Neurosci Rep       Date:  2012-12       Impact factor: 5.081

3.  Increased Risk of Intracerebral Hemorrhage Among Patients With Hepatitis C Virus Infection.

Authors:  Chun-Hung Tseng; Chih-Hsin Muo; Chung Y Hsu; Chia-Hung Kao
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.